GlobeNewswire by notified

RESULT OF RIKSBANK CERTIFICATE SALE

Share
AuctionAuction results
Auction date2021-11-23
Start date2021-11-24
Maturity date2021-12-01
Interest rate, %0.00
Offered volume, SEK bn569.0
Total bid amount, SEK bn2741.2
Accepted volume, SEK bn569.0
Number of bids16
Percentage alloted, %20.757


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Debitormassens sammensætning, Realkredit Danmark A/S24.4.2024 10:12:43 CEST | pressemeddelelse

Til Nasdaq Copenhagen A/S Direktionen Bernstorffsgade 40 1577 København V www.rd.dk Telefon 7012 5300 24. april 2024 Selskabsmeddelelse nummer 31/2024 Debitormassens sammensætning for konverterbare obligationsserier, Realkredit Danmark A/S I medfør af lov om kapitalmarkeder §24 oplyses hermed om debitormassens sammensætning vedrørende Realkredit Danmark A/S pr. fredag den 19. april 2024. Oplysningerne fremgår af vedhæftede datafil. Oplysningerne vil desuden kunne ses på Realkredit Danmarks hjemmeside på www.rd.dk. For yderligere oplysninger om dataformat og -indhold henvises til Nasdaq Copenhagen A/S’s hjemmeside. Med venlig hilsen Direktionen Eventuel henvendelse kan rettes til chefanalytiker Hella Gebhardt Rønnebæk, 45 13 20 68. Vedhæftede filer Nr. 31_Debitormassens sammensaetning_DKBilag til selskabsmeddelelse nr. 31-2024

Breakdown of debtors, Realkredit Danmark A/S24.4.2024 10:12:43 CEST | Press release

To Nasdaq Copenhagen A/S Executive Management Bernstorffsgade 40 DK-1577 København V www.rd.dk Telephone +45 7012 5300 24 April 2024 Company Announcement No 31/2024 Breakdown of debtors, Realkredit Danmark A/S Pursuant to §24 of the Capital Markets Act, Realkredit Danmark A/S hereby publishes breakdown of debtors as of Friday 19 April 2024. Please find the data in the attached file. The information will also be available on www.rd.dk. Yours sincerely The Executive Management Any additional questions should be addressed to Hella Gebhardt Rønnebæk, Chief Analyst, phone +45 4513 2068. Attachments Nr. 31_Debitormassens sammensaetning_UKBilag til selskabsmeddelelse nr. 31-2024

Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)24.4.2024 10:00:00 CEST | Press release

The confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid arthritisAlvotech is the first company to publicly announce positive topline results from a patient study evaluating a biosimilar candidate to Simponi or Simponi Aria Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive topline results from a confirmatory clinical study for AVT05, Alvotech’s proposed biosimilar to Simponi® and Simponi Aria® (golimumab). Alvotech is the first company to announce positive topline results of a clinical trial using a proposed biosimilar to Simponi and Simponi Aria and is one of only two companies known to have initiated such a patient study. “We are delighted at passing yet another clinical milestone in our pipeline,” said Robert Wessman, Chairm

Title correction: EXEL Industries : Second quarter 2023–2024 sales down 1.8%24.4.2024 09:24:17 CEST | Press release

Second quarter 2023-2024 sales: down 1.8% Varying sales performance across activities Q2 sales (January 2024–March 2024) 2022-20232023-2024Change (reported)Change (LFL*) Reported Reported €m % €m % AGRICULTURAL SPRAYING 147.7157.4 +9.7 +6.5% +12.0 +8.1% SUGAR BEET HARVESTERS 34.317.1 -17.2 -50.1% -17.1 -49.9% LEISURE 48.447.4 -1.0 -2.0% -4.4 -9.0% INDUSTRY 67.670.7 +3.1 +4.7% +3.3 +4.9%EXEL Industries Group297.9292.6 -5.3 -1.8% -6.2 -2.1% 6-month sales (October 2023–March 2024) 2022-20232023-2024Change (reported)Change (LFL*) Reported Reported €m % €m % AGRICULTURAL SPRAYING 236.8248.3 +11.6 +4.9% +17.0 +7.2% SUGAR BEET HARVESTERS 53.844.2 -9.6 -17.8% -8.5 -15.9% LEISURE 62.158.5 -3.6 -5.9% -8.8 -14.1% INDUSTRY 130.4141.7 +11.3 +8.7% +14.4 +11.0%EXEL Industries Group483.1492.7 +9.7 +2.0% +14.1 +2.9% * Like-for-like (LFL) = at constant consolidation scope and foreign exchange rates Second quarter 2023-2024 sales The EXEL Industries Group posted revenue of €292.6 million for the second q

Offentliggørelse af prospekt for Investeringsforeningen Danske Invest Select24.4.2024 09:08:50 CEST | pressemeddelelse

Vi skal herved oplyse, at der er foretaget ændringer i prospektet for Investeringsforeningen Danske Invest Select. Opdatering med 2023-tallene i afsnit 10.2 ”Omkostninger til bestyrelsen og Finanstilsynet” samt i tabel 4 ”Administrationsomkostninger de seneste 5 år”.Den årlige opdatering af den forventede indvirkning, som bæredygtighedsrisici kan have på en afdelings afkast (oplyst som "Lav", "Medium" eller "Høj") i afsnit 6 Afdelingernes/andelsklassernes risici.1 andelsklasse er taget ud af prospektet for afdeling US High Yield Bonds.Ændring af de af bestyrelsen fastsatte restriktioner og præciseringer vedrørende investeringerne for en række aktieafdelinger.Opdatering af afsnit 10.7 Porteføljeforvalter. Prospekterne kan fra i dag ses på www.danskeinvest.dk. Med venlig hilsen DANSKE INVEST MANAGEMENT A/S Tina Hjorth Hetting Head of Fund Products

HiddenA line styled icon from Orion Icon Library.Eye